We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01184326
First Posted: August 18, 2010
Last Update Posted: October 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
GlaxoSmithKline
Novartis
Information provided by (Responsible Party):
Mark Pomerantz, MD, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2017
  Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)